Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma

Endometrial carcinoma is the most common malignant tumor of the female genital tract in the United States. Epigenetic alterations are implicated in endometrial cancer development and progression. Histone deacetylase inhibitors are a novel class of anticancer drugs that increase the level of histone...

Descripción completa

Detalles Bibliográficos
Autores principales: Psilopatis, Iason, Pergaris, Alexandros, Giaginis, Constantinos, Theocharis, Stamatios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604582/
https://www.ncbi.nlm.nih.gov/pubmed/34804263
http://dx.doi.org/10.1155/2021/7850688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604582/
https://www.ncbi.nlm.nih.gov/pubmed/34804263
http://dx.doi.org/10.1155/2021/7850688

Ejemplares similares